|
Evaluation and usage of techniques for Molecular Testing in Europe analysed.
(PRWEB) August 8, 2004 -- Research and Markets announces the addition of this new report entitled "An Evaluation of Product Usage for Molecular Testing within Infectious Diseases in Europe" to its offerings.
The new report examines the reality of 221 laboratories and hospitals in 11 European countries and provides the following information:
Molecular Tests
| | - Description of laboratory landscape per country
- the number of performed tests for 47 pathogens
- which products, technologies and manufacturers are used per pathogen
- determine current laboratory equipment that is used for microbiology testing
- Unmet needs
- which tests, technologies and products show the most promising market opportunities in the short tmedium term
- market potential in volume per test, technology and country
- regulatory issues per country (legislation, reimbursement
|
Product Value Proposition
The study will allow the owner of the information to:
| | - Assess current market realities in terms of currently performed tests / Used technologies at an unparalleled level of segmentation
- Get detailed knowledge on suppliers of molecular test kits / equipment, (by segmentation criteria)
- Reflect the current situation not only at a specific point in time, but monitor trends over a period of time (both in terms of market participants as well as system types)
- Model market and own sales forecasts on system types based on investment plans of customers
- Reflect the expected behaviour of buyers, not just the expectations of sellers; but by the motivations of buyers.
- Model market forecasts on associated product lines (e.g. PCR Cycler, NAT related devices) based on procedure data
- Make decisions regarding the market entry/marketing strategy
|
Respondents have been chosen randomly in order to guarantee that the respondents reflect the real market situation. However the definition of the project required the focus on such institutions that perform molecular testing particularly.
Segmentation by Indication
Chlamydia trachomatis
Neisseria gonorrhoeae
HIV
HCV
Mycobacterium tuberculosis
Mycobacterium avium
Bordetella sp.
Legionella pneumophilia
Chlamydia sp.
Mycoplasma pneumoniae
quantitative
qualitative
| | - Virale Meningitis/Encephalitis
|
HSV 1,2
Enterovirus
West Nile Virus
SARS
Adenovirus
Influenza A
Influenza A and B
RSV
Parainfluenza
Blastomyces
Histoplasma
Cryptococcus
Coccidioides
TB
Neisseria meningitidis
Haemophilus
Pneumokokken
Listeria
Enterobacteriacea/Nonfermentors
RMSF
Babesia
Ehrlichia
Anaplasma
Borrelia
Segmentation by Technology
| | - commercial available tests with amplification (methods: PCR, LCR, SDA)
- Commercial tests without amplification (method: DNA probes)
- Others: EIA (enzyme linked tests), Antibody/Antigencomplex tests, serology, microscopy, strip tests
|
Segmentation by Country
- Germany
- UK
- France
- Italy
- Spain
- Norway
- Denmark
- Sweden
- Finland
- Belgium
- Switzerland
For a complete index of this report click on http://www.researchandmarkets.com/reports/220750
About Research and Markets Ltd.
Research and Markets Ltd. are Europe's largest resource for market research. R&M distribute thousands of major research publications from the world's leading publishers, consultants and market analysts. R&M provide you with the latest forecasts on international and regional markets, key industries, the top companies, new products and the latest market trends.
For additional information on ResearchandMarkets.com, their range of reports or their value-added services, visit their web site at http://www.researchandmarkets.com or mailto:press@researchandmarkets.com
|
